Q/C Technologies Inc (QCLS) Stock Price, Quote & News

Company Profile

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabi...

Industry: Computer Hardware

Sector: Technology

Phone: 856 848 8698

Website: www.qctechnologies.com

Address:

1185 Avenue of the Americas, Suite 249, New York, United States

MingChoo Sep. 13 at 10:09 PM

$QCLS Looking for green3

0 · Reply

LindzonForTheOven Sep. 12 at 1:09 AM

$QCLS Food for thought; that's what e1 said when they brought him on last December. They still have the lab in SF, the hired talent including the veteran chips man, Altucher etc I didn't see the share price get sheared to subatomic particles after the news hit tonight. Maybe it's all up from here. I'm probably deluding myself but hey...

0 · Reply

TurtleTeeTradez Sep. 12 at 12:32 AM

$QCLS This ticket is done! R.I.P Now we know who have been selling all that shares.

0 · Reply

Jj1369 Sep. 11 at 8:55 PM

$QCLS ahahahahah they fired the only two people within the company who even know what photonics is… THIS SCAM IS GOING TO ZERO!

0 · Reply

cats44ever Sep. 11 at 8:47 PM

$QCLS At one point last year (with Shkreli claiming they were on their way to smash through $100) they were going to 'something something' AI, for the crypto market. Now, three versions of company later, they let everthing end. Where to now?

1 · Reply

focafoca99 Sep. 11 at 8:40 PM

$QCLS ended two consulting agreements and a director resigned. https://www.rapidticker.com/news/qcls-sec-filing-d5415e

0 · Reply

Jj1369 Sep. 11 at 8:21 PM

$QCLS new lows again next week! See you at $1.50 on Monday 😎

0 · Reply

Kymoneythree Sep. 11 at 6:33 PM

$QCLS

0 · Reply

Jj1369 Sep. 10 at 8:02 PM

$QCLS under $1.00 by end of the month!!! The markets biggest scam! EASIEST SHORT TRADE OF MY LIFE

0 · Reply

TakingHearts90 Sep. 10 at 7:41 PM

$QCLS @KKEE122 starting to think he is short. Glad I exited Majority of my position at historical low support… We will watch this for now but looks dead.

0 · Reply

Q/C Technologies Quarterly report: Q2 2026

Aug 4, 2026, 9:15 AM EDT - 5 weeks ago

Q/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) Development

Jul 1, 2026, 9:44 AM EDT - 2 months ago

Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative

May 15, 2026, 7:00 AM EDT - 4 months ago

Q/C Technologies Quarterly report: Q1 2026

Apr 15, 2026, 7:00 AM EDT - 5 months ago

Q/C Technologies Annual report: Q4 2025

2026-03-18T13:20:54.000Z - 5 months ago

Q/C Technologies launches optical processing unit initiative

Mar 18, 2026, 9:15 AM EDT - 5 months ago

Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

2026-02-11T22:20:14.000Z - 7 months ago

Q/C Technologies files $100M mixed securities shelf

Feb 11, 2026, 7:00 AM EST - 7 months ago

Q/C Technologies Registration statement: Registration Filing

2026-01-20T14:25:11.000Z - 7 months ago

Q/C Technologies appoints Voss to Board of Directors

Jan 20, 2026, 9:15 AM EST - 7 months ago

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

2025-12-09T14:40:42.000Z - 9 months ago

Q/C Technologies Inc trading resumes

2025-12-09T14:35:17.000Z - 9 months ago

Q/C Technologies Inc trading halted, volatility trading pause

2025-12-09T14:20:44.000Z - 9 months ago

Q/C Technologies appoints Martin Shkreli as senior advisor

Dec 9, 2025, 9:15 AM EST - 9 months ago

Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

Dec 4, 2025, 12:05 PM EST - 9 months ago

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Nov 19, 2025, 7:00 AM EST - 9 months ago

Q/C Technologies Quarterly report: Q3 2025

2025-10-30T13:27:23.000Z - 10 months ago

Q/C Technologies enters collaboration with LightSolver

Oct 30, 2025, 9:15 AM EDT - 10 months ago

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Q/C Technologies Proxy statement: Proxy Filing

2025-10-16T13:25:30.000Z - 11 months ago

Q/C Technologies appoints Steven Frankel as senior quantum advisor

Oct 16, 2025, 9:15 AM EDT - 11 months ago

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Oct 10, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Proxy statement: Proxy Filing

2025-10-03T21:35:06.000Z - 11 months ago

Q/C Technologies files to sell 6.51M shares of common stock for holders

Oct 3, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Registration statement: Registration Filing

Sep 25, 2025, 9:15 AM EDT - 11 months ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 24, 2025, 9:15 AM EDT - 11 months ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 17, 2025, 9:24 AM EDT - 12 months ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 8, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 2, 2025, 9:20 AM EDT - 1 year ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

Sep 2, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Aug 28, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 19, 2025, 5:20 PM EDT - 1 year ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Aug 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q2 2025

Jun 24, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

May 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

May 15, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

May 8, 2025, 9:20 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

Apr 22, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Apr 16, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Annual report: Q4 2024

Mar 17, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 5, 2025, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Feb 25, 2025, 9:20 AM EST - 1 year ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Jan 29, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 15, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Dec 19, 2024, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 9, 2024, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Nov 14, 2024, 7:00 AM EST - 1 year ago

Q/C Technologies Quarterly report: Q3 2024

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Oct 2, 2024, 9:10 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Aug 21, 2024, 9:00 AM EDT - 2 years ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

MingChoo Sep. 13 at 10:09 PM

$QCLS Looking for green3

0 · Reply

LindzonForTheOven Sep. 12 at 1:09 AM

0 · Reply

TurtleTeeTradez Sep. 12 at 12:32 AM

$QCLS This ticket is done! R.I.P Now we know who have been selling all that shares.

0 · Reply

Jj1369 Sep. 11 at 8:55 PM

$QCLS ahahahahah they fired the only two people within the company who even know what photonics is… THIS SCAM IS GOING TO ZERO!

0 · Reply

cats44ever Sep. 11 at 8:47 PM

1 · Reply

focafoca99 Sep. 11 at 8:40 PM

$QCLS ended two consulting agreements and a director resigned. https://www.rapidticker.com/news/qcls-sec-filing-d5415e

0 · Reply

Jj1369 Sep. 11 at 8:21 PM

$QCLS new lows again next week! See you at $1.50 on Monday 😎

0 · Reply

Kymoneythree Sep. 11 at 6:33 PM

$QCLS

0 · Reply

Jj1369 Sep. 10 at 8:02 PM

$QCLS under $1.00 by end of the month!!! The markets biggest scam! EASIEST SHORT TRADE OF MY LIFE

0 · Reply

TakingHearts90 Sep. 10 at 7:41 PM

$QCLS @KKEE122 starting to think he is short. Glad I exited Majority of my position at historical low support… We will watch this for now but looks dead.

0 · Reply

Jj1369 Sep. 10 at 4:39 PM

$QCLS I pity the fool that thinks Martin Shkreli is going to create value for them lol “$100 near term target” Dude was only $99 off - him and his wife scammed ya’ll BIG TIME

0 · Reply

Jj1369 Sep. 10 at 4:31 PM

$QCLS the next time this closes above $2.00 will be in 6 months after the reverse split

0 · Reply

stocktwittyrock Sep. 10 at 4:07 PM

$QCLS skeli and jensen in same room all weekend. Lets see if he can pull it off!

1 · Reply

ChefCurryStocks Sep. 10 at 3:46 PM

$QCLS going to zero lol an all time scam

0 · Reply

Jj1369 Sep. 10 at 1:53 PM

$QCLS no buyers, no support, no bottom, NO HOPE LEGIT GOING TO SUB $1.00 EOM THEY HAVENT EVEN RAISED CAPITAL YET!! GOING TO PENNYLAND

0 · Reply

Jj1369 Sep. 10 at 1:48 PM

$QCLS NEW ALL TIME LOWS HAHAHA THIS SCAM IS GOING TO ZERO!

0 · Reply

TakingHearts90 Sep. 9 at 8:30 PM

$QCLS

0 · Reply

TakingHearts90 Sep. 9 at 8:29 PM

$QCLS

0 · Reply

Jj1369 Sep. 9 at 4:18 PM

$QCLS you can sell now and save yourself about 40% more lost value This is where this is heading

0 · Reply

Kymoneythree Sep. 9 at 4:13 PM

$QCLS dump it!!

0 · Reply

Jj1369 Sep. 9 at 4:10 PM

$QCLS looks like yesterdays volume was some shorts closing out just to pile back in lol NEW ALL TIME LOWS

0 · Reply

Jj1369 Sep. 9 at 2:07 PM

$QCLS hahahahaha disaster candle

0 · Reply

Market Cap	14.01M
Revenue (ttm)	0.00
Net Income (ttm)	-11.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	241,900
Avg Vol	189,428
Day's Range	N/A - N/A
Shares Out	8.19M
Stochastic %K	9%
Beta	2.09
Analysts	Strong Buy
Price Target	N/A